Tilray | TRLY - Les Charges D'Exploitation





Les Charges D'Exploitation Changement Date
Acasti Pharma USD 55.48M 7.27M 2026-09
Akebia Therapeutics USD 63.08M 8.26M 2025-12
Alaunos Therapeutics USD 952K 60K 2026-06
Aurora Cannabis CAD 76.28M 28.24M 2026-06
Avita Medical AUD 28.56M 534K 2026-06
Canopy Growth CAD 98.74M 23K 2026-06
Cronos Group USD -33.51M 78.92M 2026-09
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Divis Laboratories Ltd INR 22.52B 3.01B 2026-09
Ionis Pharmaceuticals USD 373M 2.76M 2026-09
IQVIA Holdings USD 3.82B 2.05B 2026-09
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Moderna USD 1.18B 223M 2026-09
Organigram Holdings CAD 100.45M 30.86M 2026-06
Organon & Co USD 1.19B 187M 2026-09
Revvity USD 604.27M 719K 2026-09
Tectonic Therapeutic USD 24.22M 3.08M 2026-06
Tilray USD 237.52M 17.34M 2025-09
Viatris USD 3.49B 189.1M 2026-09
Xeris Pharmaceuticals USD 86.93M 11.72M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03